22 May 2013
Keywords: pfizer, caduet, reduces, 10-yr, cv, risk, amlodipine
Article | 23 October 2006
Pfizer's Caduet (amlodipine besylate and atorvastatin calcium) may reduce the 10-year risk of having a cardiovascular event 54% in
hypertensive patients ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 October 2006
21 May 2013
© 2013 thepharmaletter.com